Michael Healy-Rae
Ceist:520. Deputy Michael Healy-Rae asked the Minister for Health the recorded cases of vasculitis following HPV immunisation (details supplied); and if he will make a statement on the matter. [12243/18]
Amharc ar fhreagraTuesday, 20 March 2018
Ceisteanna (520)
Freagraí scríofa
The information that the Deputy seeks with regard to recorded cases of vasculitis following HPV immunisation is not readily available. Therefore, I have asked the Health Products Regulatory Authority (HPRA) to investigate the matter and reply directly to the Deputy.
It is important to reiterate that the HPRA and the European Medicines Agency continually monitor adverse events to vaccination. HPV is one of the most closely studied and monitored medicinal products. The vast majority of reports received by the HPRA have been consistent with the expected pattern of short term adverse side effects for the vaccine, as described in the product information. Mild and temporary reactions to any kind of vaccination are not unusual.